The store will not work correctly when cookies are disabled.
5-Naphthalen-1-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA432556
PubChem CID: 9971803
Max Phase: Preclinical
Molecular Formula: C21H16N2
Molecular Weight: 296.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C1=C(c2cccc3ccccc23)N2CCN=C2c2ccccc21
Standard InChI: InChI=1S/C21H16N2/c1-3-9-17-15(6-1)8-5-11-19(17)20-14-16-7-2-4-10-18(16)21-22-12-13-23(20)21/h1-11,14H,12-13H2
Standard InChI Key: SYOXVJRKJAQPGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 27 0 0 0 0 0 0 0 0999 V2000
4.1625 -5.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1292 -6.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6125 -6.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 -5.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6917 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1000 -6.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6125 -7.0917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -4.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6500 -6.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2500 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6500 -7.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2000 -5.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -6.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6042 -5.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2167 -4.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7292 -5.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7542 -4.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2750 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0542 -6.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0667 -5.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2417 -3.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7750 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 1 1 0
6 8 2 0
7 3 2 0
8 4 1 0
9 5 1 0
10 2 1 0
11 9 1 0
12 10 1 0
13 5 2 0
14 6 1 0
15 8 1 0
16 9 2 0
17 13 1 0
18 17 2 0
19 11 2 0
20 21 1 0
21 15 2 0
22 16 1 0
23 22 2 0
6 3 1 0
7 12 1 0
11 18 1 0
19 23 1 0
20 14 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.37 | Molecular Weight (Monoisotopic): 296.1313 | AlogP: 4.41 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.03 | CX LogP: 4.05 | CX LogD: 3.90 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.65 | Np Likeness Score: -0.16 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |